Young Ho Park1, Beom Joon Kim, Jun-Soon Kim, Mi Hwa Yang, Myung Suk Jang, Nayoung Kim, Moon-Ku Han, Ji Sung Lee, Juneyoung Lee, Sangyun Kim, Hee-Joon Bae. 1. From the Department of Neurology, Seoul National University Bundang Hospital, Seongnam, Korea (Y.H.P., B.J.K., M.H.Y., M.S.J., M.-K.H., S.Y.K., H.-J.B.); Department of Neurology, Seoul National University College of Medicine, Korea (Y.H.P., B.J.K., J.-S.K., M.-K.H., S.Y.K., H.-J.B.); Department of Neurology, Dong-A University Medical Center, Busan, Korea (N.K.); Biostatistical Consulting Unit, Soonchunhyang University Medical Center, Seoul, Korea (J.S.L.); and Department of Biostatistics, College of Medicine, Korea University, Seoul, Korea (J.L.).
Abstract
BACKGROUND AND PURPOSE: Although both ends of the hemoglobin range may negatively influence clinical outcomes in acute ischemic stroke, most studies have examined the linear relationship or focused on the lower end of the range. Furthermore, it is unclear whether hemoglobin concentrations at different time points during hospitalization correlate with clinical outcomes in the same manner. METHODS: We identified 2681 consecutive patients with acute ischemic stroke from a prospective stroke registry database and grouped them into hemoglobin concentration quintiles using the following 5 indices: initial, nadir, time-averaged, discharge hemoglobin, and hemoglobin drop. To examine the effect of both ends of hemoglobin range, the third quintile was selected as a reference category except for hemoglobin drop, for which the first quintile was used. As outcome variables, 3-month modified Rankin Scale as an ordinal scale and 3-month mortality were used. RESULTS: With respect to higher modified Rankin Scale scores, the adjusted odds ratios and 95% confidence intervals of the first quintiles of initial, nadir, time-averaged, and discharge hemoglobin were 1.74 (1.31-2.31), 2.64 (2.09-3.33), 1.81 (1.42-2.30), and 1.65 (1.29-2.13), respectively. The opposite ends of these hemoglobin indices were not significantly associated. The adjusted odds ratio of the fifth quintile of hemoglobin drop (greatest hemoglobin drop) was 2.09 (1.51-2.89). The mortality analysis showed similar results except for initial hemoglobin. CONCLUSIONS: In acute ischemic stroke, poor outcome was related to the lower but not the higher end of the hemoglobin range, regardless of when and how hemoglobin concentrations were measured.
BACKGROUND AND PURPOSE: Although both ends of the hemoglobin range may negatively influence clinical outcomes in acute ischemic stroke, most studies have examined the linear relationship or focused on the lower end of the range. Furthermore, it is unclear whether hemoglobin concentrations at different time points during hospitalization correlate with clinical outcomes in the same manner. METHODS: We identified 2681 consecutive patients with acute ischemic stroke from a prospective stroke registry database and grouped them into hemoglobin concentration quintiles using the following 5 indices: initial, nadir, time-averaged, discharge hemoglobin, and hemoglobin drop. To examine the effect of both ends of hemoglobin range, the third quintile was selected as a reference category except for hemoglobin drop, for which the first quintile was used. As outcome variables, 3-month modified Rankin Scale as an ordinal scale and 3-month mortality were used. RESULTS: With respect to higher modified Rankin Scale scores, the adjusted odds ratios and 95% confidence intervals of the first quintiles of initial, nadir, time-averaged, and discharge hemoglobin were 1.74 (1.31-2.31), 2.64 (2.09-3.33), 1.81 (1.42-2.30), and 1.65 (1.29-2.13), respectively. The opposite ends of these hemoglobin indices were not significantly associated. The adjusted odds ratio of the fifth quintile of hemoglobin drop (greatest hemoglobin drop) was 2.09 (1.51-2.89). The mortality analysis showed similar results except for initial hemoglobin. CONCLUSIONS: In acute ischemic stroke, poor outcome was related to the lower but not the higher end of the hemoglobin range, regardless of when and how hemoglobin concentrations were measured.
Authors: Valerian L Altersberger; Lars Kellert; Abdulaziz S Al Sultan; Nicolas Martinez-Majander; Christian Hametner; Ashraf Eskandari; Mirjam R Heldner; Sophie A van den Berg; Andrea Zini; Visnja Padjen; Georg Kägi; Alessandro Pezzini; Alexandros Polymeris; Gian M DeMarchis; Marjaana Tiainen; Silja Räty; Stefania Nannoni; Simon Jung; Thomas P Zonneveld; Stefania Maffei; Leo Bonati; Philippe Lyrer; Gerli Sibolt; Peter A Ringleb; Marcel Arnold; Patrik Michel; Sami Curtze; Paul J Nederkoorn; Stefan T Engelter; Henrik Gensicke Journal: Eur Stroke J Date: 2019-11-13
Authors: Raphae S Barlas; Katie Honney; Yoon K Loke; Stephen J McCall; Joao H Bettencourt-Silva; Allan B Clark; Kristian M Bowles; Anthony K Metcalf; Mamas A Mamas; John F Potter; Phyo K Myint Journal: J Am Heart Assoc Date: 2016-08-17 Impact factor: 5.501
Authors: Alfred Anselme Dabilgou; Alassane Dravé; Julie Marie Adeline Kyelem; Saïdou Ouedraogo; Christian Napon; Jean Kaboré Journal: Stroke Res Treat Date: 2020-06-11
Authors: Sebastian Bellwald; Rupashani Balasubramaniam; Michael Nagler; Meret S Burri; Samuel D A Fischer; Arsany Hakim; Tomas Dobrocky; Yannan Yu; Fabien Scalzo; Mirjam R Heldner; Roland Wiest; Marie-Luise Mono; Hakan Sarikya; Marwan El-Koussy; Pasquale Mordasini; Urs Fischer; Gerhard Schroth; Jan Gralla; Heinrich P Mattle; Marcel Arnold; David Liebeskind; Simon Jung Journal: PLoS One Date: 2018-09-26 Impact factor: 3.240